AIVF

Tel Aviv, Israel Founded: 2018 • Age: 8 yrs
AI-based platform for analyzing embryos in IVF treatments is provided.
Annual revenue - Latest available
Total funding $25.0M 1 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 4 Services tracked
Competitors 10 Brand Intelligence

About AIVF

AIVF is a company based in Tel Aviv (Israel) founded in 2018 by Daniel Seidman, Daniella Gilboa, and Eyal Schiff. AIVF has raised $25 million across 1 funding round from investors including Insight Partners and Dan Ariely. AIVF has completed 1 acquisition, including ART Compass. AIVF offers products and services including EMA Platform, AIVF Day-3, AIVF Day-5, and AIVF Genetics. AIVF operates in a competitive market with competitors including Seragen, IVF, BAIBYS, Inanna Fertility and SpOvum Technologies, among others.

  • Headquarter Tel Aviv, Israel
  • Founders Daniel Seidman, Daniella Gilboa, Eyal Schiff
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $25 M (USD)

    in 1 rounds

  • Latest Funding Round
    $25 M (USD), Series A

    Jun 22, 2022

  • Investors
  • Employee Count
    Not available
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of AIVF

AIVF offers a comprehensive portfolio of products and services, including EMA Platform, AIVF Day-3, AIVF Day-5, and AIVF Genetics.

Product name locked
Category locked
Primary

Platform for embryo evaluation to improve IVF success rates.

Product name locked
Category locked
Locked

Tool for assessing day-3 embryos in fertility treatments.

Product name locked
Category locked
Locked

Software for evaluating day-5 embryos to enhance outcomes.

Product name locked
Category locked
Locked

Service for genetic screening in IVF processes.

People of AIVF

Headcount 10-50
Employee Profiles 14
Board Members and Advisors 5
Employee Profiles
People
Yariv Zur
VP Product
People
Daniel Seidman
Co-Founder & CMO
People
Eyal Ohayon
Evp, Engineering
People
Jason Krebs
Chief Business Officer

Unlock access to complete

Board Members and Advisors
people
Colin Howles
Board Member
people
Lee Shulman
Board Member
people
Nikica Zaninovic
Board Member
people
Barry Behr
Board Member

Unlock access to complete

Funding Insights of AIVF

AIVF has successfully raised a total of $25M through 1 strategic funding round. The most recent funding activity was a Series A round of $25 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in AIVF

AIVF has secured backing from 2 investors, including venture fund and angel investors. Prominent investors backing the company include Insight Partners and Dan Ariely.

All
Venture Fund
Angel
Investor Description Founded Year Domain Location
Investment firm scaling software and technology companies from early to late stages.
Locked Locked Locked

Dan Ariely

Behavioral economist, author, and angel investor in tech and consumer startups.
Locked Locked Locked
Premium access

Investor details for AIVF

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by AIVF

AIVF has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ART Compass.

Investments
Premium access

Investment portfolio details for AIVF

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
EHR and practice management app for IVF clinics is provided.
Locked Locked 2018 Locked
Premium access

Complete acquisition details for AIVF

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - AIVF

Premium access

Detailed financials for AIVF

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Aivf Comparisons

AIVF Primary company
Description
AI-based platform for analyzing embryos in IVF treatments is...
Location
Tel Aviv, Israel
Founded Year
2018
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for AIVF

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of AIVF

AIVF operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Seragen, IVF, BAIBYS, Inanna Fertility and SpOvum Technologies, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Point-of-care therapeutics and AI platform are offered for infertility treatment.
Locked Locked Locked
Provider of AI based decision-making tools for IVF professionals
Locked Locked Locked
AI-based sperm selection is provided to healthcare providers.
Locked Locked Locked
Delivers a clinical decision support tool for IVF clinics.
Locked Locked Locked
Develops automation solutions for ART procedures in fertility clinics and embryology.
Premium access

Detailed competitors of AIVF

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Aivf

Premium access

Complete news archive for AIVF

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about AIVF

AIVF was founded in 2018 and raised its 1st funding round 4 years after it was founded.

AIVF is headquartered in Tel Aviv, Israel.

Daniella Gilboa is the current CEO of AIVF. They have also founded this company.

AIVF is a funded company, having raised a total of $25M across 1 funding round to date.

AIVF was established in 2018 in Tel Aviv, Israel, within the healthcare technology sector. An AI-driven diagnosis platform for in vitro fertilization (IVF) is offered. Images and videos of developing embryos are examined through deep learning algorithms. Patient electronic medical records, genomic information, and visual data are integrated to inform critical decisions in treatment processes. Operations focus on supporting fertility clinics with data-driven insights.

AIVF's top competitors include BAIBYS, Seragen and IVF.

AIVF offers EMA Platform, AIVF Day-3, AIVF Day-5, and AIVF Genetics.

AIVF has made 1 acquisition, including ART Compass.

AIVF has 2 investors. Key investors include Insight Partners, and Dan Ariely.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available